• Seeking Alpha

Basilea gibt Verkaufsstart seines Antibiotikums Zevtera® (Ceftobiprol) in den USA bekannt

Seeking Alpha / 3 hours ago 3 Views

Allschwil, 20. Mai 2025

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
Next post
Consistent with the strategic plan presented at the beginning of the year: Leumi continues to show high double-digit returns - and a net income of NIS 2.4 billion ($646 million) in the first quarter of 2025

Comments

Just Posted

  • Syntec Optics (Nasdaq: OPTX) Enabling Optics for Fusion Energy, Enters New End-Market

    3 hours from now

  • Birchtech to Exhibit at American Water Works Association Annual “ACE 25” Conference from June 8-11, 2025

    3 hours from now

  • Mama’s Creations to Host First Quarter Fiscal 2026 Earnings Call on June 3 at 4:30 p.m. Eastern Time

    3 hours from now

  • KULR Expands Bitcoin Holdings to 800 BTC, Reports 220.2% BTC Yield

    3 hours from now

  • LPL Financial Announces Q1 2025 Technology Updates

    3 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1262

Categories

  • Seeking Alpha 1262

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts